This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Mark Chiu, PhD
Co-founder - Entrepreneur at Qilin Glen LLC
Speaker

Agenda Sessions

  • Promising Clinical Profiles of TAVO412, a Trispecific EGFR x cMET x VEGF antibody, in Patients with Multiple Solid Tumors

    , 10:00
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Mark at Antibody Engineering & Therapeutics Europe